Catalyst Wire Dossier Catalyst Wire Dossier

Empliciti

elotuzumab · Bristol Myers Squibb
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for Empliciti, covering 2015-09-04 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

See pricing